Cartesian Therapeutics RNAC
NASDAQ RNAC
$7.36 +0.14 (+1.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cartesian Therapeutics (RNAC) Price to FCF (2020 - 2021)

Updated

Cartesian Therapeutics' Price to FCF came in at 369.20 for Q2 2021, down 18.8% from the prior quarter.

Analysis

Cartesian Therapeutics (RNAC) Price to FCF (2020 - 2021) Analysis & Trends

For FY2020, Cartesian Therapeutics' Price to FCF was 288.37.

  • The five-year range for quarterly Price to FCF is 279.03 (Q3 2020) to 454.54 (Q1 2021).
  • Business Quant data shows RNAC's Price to FCF at 454.54 (Q1 2021), 288.37 (Q4 2020) and 279.03 (Q3 2020) in the three quarters before Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Cartesian Therapeutics 216.87 Mn 216.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 369.20
Mar 31, 2021 454.54
Dec 31, 2020 288.37
Sep 30, 2020 279.03
API Access

Cartesian Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=RNAC&period=max&api_key=YOUR_API_KEY